Lupus Intervention for Fatigue Trial
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Lupus, Other Indications |
| Therapuetic Areas: | Immunology / Infectious Diseases, Other |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 8/24/2018 |
| Start Date: | January 2019 |
| End Date: | December 2022 |
| Contact: | Karen Mancera Cuevas, MS, MPH |
| Email: | k-mancera-cuevas@northwestern.edu |
| Phone: | 312-503-0251 |
Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will
be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons
with systemic lupus erythematosus (SLE). The intervention group will receive individual
coaching and group educational sessions focusing on physical activity and nutrition while the
control group will receive individual calls in relation to SLE self-management group
educational sessions.This study is designed to evaluate the LIFT intervention to decrease
fatigue (primary outcome), improve physical activity (secondary outcome) and dietary behavior
(exploratory outcome) in persons with SLE.
be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons
with systemic lupus erythematosus (SLE). The intervention group will receive individual
coaching and group educational sessions focusing on physical activity and nutrition while the
control group will receive individual calls in relation to SLE self-management group
educational sessions.This study is designed to evaluate the LIFT intervention to decrease
fatigue (primary outcome), improve physical activity (secondary outcome) and dietary behavior
(exploratory outcome) in persons with SLE.
Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will
be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons
with systemic lupus erythematosus (SLE). The intervention group will receive individual
coaching based in motivational interviewing and group educational sessions focusing on
physical activity and nutrition while the control group will receive individual calls and
group sessions focusing on SLE self-management. This study is designed to evaluate the LIFT
intervention to decreased fatigue (primary outcome), improve physical activity (secondary
outcome) and dietary behavior (exploratory outcome) in persons with SLE.
be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons
with systemic lupus erythematosus (SLE). The intervention group will receive individual
coaching based in motivational interviewing and group educational sessions focusing on
physical activity and nutrition while the control group will receive individual calls and
group sessions focusing on SLE self-management. This study is designed to evaluate the LIFT
intervention to decreased fatigue (primary outcome), improve physical activity (secondary
outcome) and dietary behavior (exploratory outcome) in persons with SLE.
Inclusion criteria:
- include meeting at least 4 of 11 American College of Rheumatology (ACR) classification
criteria for definite SLE, or 3 out of 11 ACR classification criteria with also
meeting at least one SLICC criteria
- be at least 18 years of age
- have a BMI between 18-40 kg/m2
- be able to ambulate at least household distances (50ft)
- be able to provide informed consent.
Exclusion criteria:
- include pregnancy at baseline
- not meeting inclusion criteria.
We found this trial at
1
site
Click here to add this to my saved trials
